LAUSR

update could include more prognostic information into the risk calculation, including genetic scores, plasma biomarkers of even imaging like coronary CT angiography. Of course, the fundamental question is whether this personalized risk prediction can be used to guide individual patient clinical management, or whether a blanket approach of prescribing a polypill without sophisticated risk assessment, would offer a good alternative, particularly in financially less developed countries. CVD, European Society lipoprotein.